You just read:

SillaJen and Transgene Announce the Enrollment of the First European Patient in Multinational Phase 3 Trial for Pexa-Vec in Advanced Liver Cancer

News provided by

SillaJen, Inc.

24 Apr, 2017, 11:45 ET